Alaunos Therapeutics, Inc. (TCRT)
NASDAQ: TCRT · Real-Time Price · USD
2.950
-1.270 (-30.09%)
At close: Apr 4, 2025, 4:00 PM
3.150
+0.200 (6.78%)
After-hours: Apr 4, 2025, 7:59 PM EDT

Alaunos Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-4.68-35.14-37.73-78.75-79.98
Upgrade
Depreciation & Amortization
02.322.762.61.13
Upgrade
Other Amortization
-1.340.980.38-
Upgrade
Loss (Gain) From Sale of Assets
-0.010.01--
Upgrade
Asset Writedown & Restructuring Costs
-4.8-0.74-
Upgrade
Stock-Based Compensation
0.442.83.5310.776.83
Upgrade
Other Operating Activities
--0.010.35-0.35-
Upgrade
Change in Accounts Receivable
-01.113.56-1.34
Upgrade
Change in Accounts Payable
-0.1-0.77-0.030.270.05
Upgrade
Change in Other Net Operating Assets
-0.63-5.48-0.21-0.6916.29
Upgrade
Operating Cash Flow
-4.97-30.14-29.23-61.47-57.01
Upgrade
Capital Expenditures
--0.2-0.22-3.32-9.78
Upgrade
Sale of Property, Plant & Equipment
-1.540.02--
Upgrade
Investing Cash Flow
-1.35-0.19-3.32-9.78
Upgrade
Long-Term Debt Issued
---25-
Upgrade
Long-Term Debt Repaid
--18.11-8.33--
Upgrade
Net Debt Issued (Repaid)
--18.11-8.3325-
Upgrade
Issuance of Common Stock
-0.0914.751.04102.12
Upgrade
Repurchase of Common Stock
---0.05--
Upgrade
Other Financing Activities
--0.13--0.26-
Upgrade
Financing Cash Flow
--18.146.3725.78102.12
Upgrade
Net Cash Flow
-4.97-46.93-23.06-39.0235.33
Upgrade
Free Cash Flow
-4.97-30.34-29.45-64.79-66.79
Upgrade
Free Cash Flow Margin
-49710.00%-606780.00%-1007.80%-16279.15%-
Upgrade
Free Cash Flow Per Share
-3.10-18.97-20.34-45.33-47.79
Upgrade
Cash Interest Paid
-2.062.170.63-
Upgrade
Levered Free Cash Flow
-3.73-5.1-27.95-33.39-36.02
Upgrade
Unlevered Free Cash Flow
-3.73-5.24-26.96-33.03-36.02
Upgrade
Change in Net Working Capital
0.73-7.6612.57-2.64-16.03
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q